Trial · NCT02111499
Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test
NCT02111499, Phase 1, Phase 2, Completed, Almirall, S.A.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test. Trials, record NCT02111499. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02111499
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test
- NCT number
- NCT02111499
- Status
- Completed
- Phases
- Phase 1, Phase 2
- Enrollment
- 18 participants, actual
- Lead sponsor
- Almirall, S.A.
- Conditions
- Psoriasis
- Interventions
- LAS41004-IMP1, LAS41004 IMP2, LAS41004 IMP3, LAS41004 IMP4, LAS41004 IMP6, LAS41004 IMP5
- First posted
- 2014-04-11
- Last updated
- 2014-06-09
- Other registries' IDs
- eudract:2013-003754-24
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Area under the curve, AUC, of the width of the echo-lucent band based on sonography measurements | day 1 vs day 29 | The primary objective is to gain evidence suggesting efficacy of the investigational products in the treatment of plaque-type psoriasis as assessed by the AUC of the width of the echo-lucent band |
| Secondary | erythema and induration | day 1 vs day 29 | investigation of the individual scores for erythema and induration |
| Secondary | local skin tolerability | every day for 28 days | Safety investigation of tolerability parameters assessed by a dermatologist |
| Secondary | atrophy | day1 vs day 29 | investigation of skin atrophy assessments on non-lesional test areas |
| Secondary | assessment of (serious) Adverse Events | from baseline to day 29 | Daily record will be performed and - if needed - causality and severity assessed |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02111499
GET https://conductscience.org/api/trials/v1/NCT02111499/registered